Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.
Thanks to the work of NEI scientists and grantees, we’re constantly learning new information about the causes and treatment of vision disorders. Get the latest updates about their work — along with other news about NEI.
An artificial intelligence (AI) device that has been fast-tracked for approval by the Food and Drug Administration may help identify newborns at risk for aggressive posterior retinopathy of prematurity (AP-ROP). AP-ROP is the most severe form of ROP.
According to a study from Emory University, as young as six days a baby’s brain appears hardwired for the specialized tasks of seeing faces and seeing places.
Neuroscientists at the University of South Florida have become the first to definitively prove pressure in the eye is sufficient to cause and explain glaucoma.
Researchers at UW Medicine have decoded what makes good lighting – lighting capable of stimulating the cone photoreceptor inputs to specific neurons in the eye that regulate circadian rhythms.
New research by bioengineer David Schmidtke is helping understand how corneal repair cells called keratocytes sometimes result in scarring and blindness.
Missing a single ophthalmology appointment over a two-year period was associated with decreased visual acuity for patients with macular degeneration according to a new Penn Medicine study.
An artificial intelligence algorithm that can detect a potentially devastating cause of childhood blindness better than most human experts has been granted breakthrough status by the FDA.
Researchers at the University of Virginia have successfully treated age-related macular degeneration (AMD) in mice after finding an unexpected link between the two main forms of the blinding eye disease.
In a new study from Virginia Tech, neuroscientists reveal a surprising clue about how the intricate visual processing system forms during early brain development.